On the 1st, the Japanese Society of Nephrology released an interim report from a survey conducted among its member doctors regarding the issue of kidney disease among people who consumed health foods containing Kobayashi Pharmaceutical's red yeast rice. So far, 47 patients have been reported from all over the country who have had kidney function problems after taking these products, and 80% of these cases were concentrated after January of this year. .
The Japanese Society of Nephrology has been conducting a survey of its member doctors for the past day to see if any patients have experienced impaired kidney function after taking the three types of Kobayashi Pharmaceutical products that are subject to the recall. , published an interim report.
According to the report, 47 patients from all over the country have been reported to have impaired kidney function, of which 46 took "Red Yeast Choleste Help" and 1 took "Naishi Help + (Plus) Cholesterol." That means he was doing it.
Approximately 90% are between the ages of 40 and 69, and nearly 70% are women.
The earliest patient to receive a medical examination was November last year, and 80% of the patients visited the hospital after January this year.
Additionally, more than half of the patients
complained of symptoms such as
malaise,
decreased appetite
, urinary abnormalities , and impaired kidney function, and
nearly 20% of patients
complained of
abdominal symptoms and weight loss.
about it.
Approximately three-quarters of patients improved their symptoms after stopping the product
; one-quarter of patients received steroid treatment, and
two patients received dialysis.
No deaths have been reported so far.
Yoshitaka Isaka, vice president of the Japanese Society of Nephrology, said, ``While it is necessary to verify the causal relationship with intake, many people's kidney function improved after they stopped taking the product, so people taking the product in question should immediately It is important to stop and get tested."